| Identification | |
| Name: | L-Norleucine,6-hydroxy- |
| Synonyms: | Norleucine,6-hydroxy-, L- (8CI); (+)-L-e-Hydroxynorleucine; (S)-2-Amino-6-hydroxyhexanoic acid;6-Hydroxy-L-norleucine; L-2-Amino-6-hydroxyhexanoic acid; L-Hexahomoserine; L-a-Amino-e-hydroxy-n-caproic acid; L-e-Hydroxynorleucine; NSC 206290 |
| CAS: | 6033-32-5 |
| Molecular Formula: | C6H13 N O3 |
| Molecular Weight: | 147.1723 |
| InChI: | InChI=1/C28H28F3N5O3S/c29-28(30,31)20-7-4-8-23(15-20)34-11-13-35(14-12-34)25(38)16-21-18-40-27(32-21)33-24(37)17-36(22-9-10-22)26(39)19-5-2-1-3-6-19/h1-8,15,18,22H,9-14,16-17H2,(H,32,33,37) |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 172.6°C |
| Boiling Point: | 361.7°Cat760mmHg |
| Density: | 1.189g/cm3 |
| Refractive index: | 1.644 |
| Flash Point: | 172.6°C |
| Usage: | A key chiral intermediate used for synthesis of a vasopeptidase inhibitor |
| Safety Data | |
 |
|
